Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Gains from Investment Securities (2019 - 2025)

ENDRA Life Sciences has reported Gains from Investment Securities over the past 3 years, most recently at $262481.0 for Q4 2021.

  • Quarterly Gains from Investment Securities rose 172.09% to $262481.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $262481.0 through Dec 2021, changed N/A year-over-year, with the annual reading at $492352.0 for FY2025, 15.75% down from the prior year.
  • Gains from Investment Securities was $262481.0 for Q4 2021 at ENDRA Life Sciences, down from $3.6 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $3.6 million in Q3 2021 and troughed at -$424210.0 in Q4 2019.
  • The 3-year median for Gains from Investment Securities is $262481.0 (2021), against an average of $413817.0.
  • Year-over-year, Gains from Investment Securities soared 2504.18% in 2020 and then decreased 15.95% in 2021.
  • A 3-year view of Gains from Investment Securities shows it stood at -$424210.0 in 2019, then grew by 14.17% to -$364113.0 in 2020, then skyrocketed by 172.09% to $262481.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Gains from Investment Securities are $262481.0 (Q4 2021), $3.6 million (Q3 2021), and $331520.0 (Q1 2021).